Novartis Brazil

Last updated: 01.06.2015

Address: Av. Prof. Vicente Rao, 90 Brooklin – São Paulo-SP,Brazil

Tel: +55 11 5532 7122


Company description

Novartis provides healthcare solutions that address the changing needs of patients and the public. Focused solely on healthcare, the company offers a diversified portfolio to best meet these needs: innovative medicines and generics, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in all these areas. In 2010, the Group achieved net sales of $ 50.6 billion, while about $ 9.1 billion was invested in research and development across the Group. Headquartered in Basel, Switzerland, the Novartis Group of companies employ approximately 119,000 people (including 16,700 from Alcon) and operate in approximately 140 countries around the world.

In Brazil, Novartis has consolidated its position as the number one research-based pharmaceutical company. Novartis is the only global company producing APIs in Brazil, which is one of the key health industrial policy objectives of the Brazilian government, and is the only global pharmaceutical company building a new biotech factory.

Products and services

Bravo (valsartan)
Brav HCT (valsartan HCT)
Bramlea (valsartan, amlodipine).



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here